SML Biopharm Co. Ltd. is harnessing mRNA technology to develop novel immunotherapy-based cancer vaccines, including two candidates for cervical and head and neck cancers caused by human papillomavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results